Mitochondrial Activity of Human Umbilical Cord Mesenchymal Stem Cells

Overview

Journal Brain Circ

Date 2021 Jun 4

PMID 34084975

Citations 11

Authors

Blaise M Cozene

Eleonora Russo

Rita Anzalone

Giampiero La Rocca

Cesario V Borlongan

Affiliations

Soon will be listed here.

Abstract

Human umbilical cord mesenchymal stem cells (hUC-MSCs) serve as a potential cell-based therapy for degenerative disease. They provide immunomodulatory and anti-inflammatory properties, multipotent differentiation potential and are harvested with no ethical concern. It is unknown whether MSCs collected from different areas of the human umbilical cord elicit more favorable effects than others. Three MSC populations were harvested from various regions of the human umbilical cord: cord lining (CL-MSCs), perivascular region (PV-MSCs), and Wharton's jelly (WJ-MSCs). Mesenchymal markers (CD90 and CD73) were expressed by all three cell populations. Stemness marker (OCT4), endothelial cell adhesion molecular marker (CD146), and monocyte-macrophage marker (CD14) were expressed by WJ-MSCs, PV-MSCs, and CL-MSCs, respectively. Stroke presents with oxygen and glucose deprivation and leads to dysfunctional mitochondria and consequently cell death. Targeting the restoration of mitochondrial function in the stroke brain through mitochondrial transfer may be effective in treating stroke. exposure to ambient and OGD conditions resulted in CL-MSCs number decreasing the least post-OGD/R exposure, and PV-MSCs exhibiting the greatest mitochondrial activity. All three hUC-MSC populations presented similar metabolic activity and survival in normal and pathologic environments. These characteristics indicate hUC-MSCs potential as a potent therapeutic in regenerative medicine.

Citing Articles

Mitochondrial Transportation, Transplantation, and Subsequent Immune Response in Alzheimer's Disease: An Update.

Javadpour P, Abbaszadeh F, Ahmadiani A, Rezaei M, Ghasemi R Mol Neurobiol. 2024; 61(9):7151-7167.

PMID: 38368286 DOI: 10.1007/s12035-024-04009-7.

LCP1 knockdown in monocyte-derived macrophages: mitigating ischemic brain injury and shaping immune cell signaling and metabolism.

Wang Y, Yin Q, Yang D, Jin H, Yao Y, Song J Theranostics. 2024; 14(1):159-175.

PMID: 38164159 PMC: 10750214. DOI: 10.7150/thno.88678.

The Truth Is Out There: Biological Features and Clinical Indications of Extracellular Vesicles from Human Perinatal Stem Cells.

Russo E, Alberti G, Corrao S, Borlongan C, Miceli V, Conaldi P Cells. 2023; 12(19).

PMID: 37830562 PMC: 10571796. DOI: 10.3390/cells12192347.

Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.

Russo E, Corrao S, Di Gaudio F, Alberti G, Caprnda M, Kubatka P Cells. 2023; 12(12).

PMID: 37371134 PMC: 10297457. DOI: 10.3390/cells12121664.

Cerebral Glucose Metabolism and Potential Effects on Endoplasmic Reticulum Stress in Stroke.

Guo S, Wehbe A, Syed S, Wills M, Guan L, Lv S Aging Dis. 2023; 14(2):450-467.

PMID: 37008060 PMC: 10017147. DOI: 10.14336/AD.2022.0905.

References

Tajiri N, Duncan K, Antoine A, Pabon M, Acosta S, De la Pena I . Stem cell-paved biobridge facilitates neural repair in traumatic brain injury. Front Syst Neurosci. 2014; 8:116. PMC: 4068001. DOI: 10.3389/fnsys.2014.00116. View

Russo E, Nguyen H, Lippert T, Tuazon J, Borlongan C, Napoli E . Mitochondrial targeting as a novel therapy for stroke. Brain Circ. 2018; 4(3):84-94. PMC: 6187947. DOI: 10.4103/bc.bc_14_18. View

Lavrentieva A, Majore I, Kasper C, Hass R . Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal. 2010; 8:18. PMC: 2918620. DOI: 10.1186/1478-811X-8-18. View

Xia C, Yin H, Borlongan C, Chao J, Chao L . Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Hum Gene Ther. 2005; 15(12):1243-54. DOI: 10.1089/hum.2004.15.1243. View

Yang J, Mukda S, Chen S . Diverse roles of mitochondria in ischemic stroke. Redox Biol. 2018; 16:263-275. PMC: 5854930. DOI: 10.1016/j.redox.2018.03.002. View

Saporta S, Cameron D, Borlongan C, Sanberg P . Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression. Exp Neurol. 1997; 146(2):299-304. DOI: 10.1006/exnr.1997.6493. View

Borlongan C, Sanberg P, Freeman T . Neural transplantation for neurodegenerative disorders. Lancet. 1999; 353 Suppl 1:SI29-30. DOI: 10.1016/s0140-6736(99)90229-5. View

La Rocca G, Lo Iacono M, Corsello T, Corrao S, Farina F, Anzalone R . Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy. Curr Stem Cell Res Ther. 2013; 8(1):100-13. DOI: 10.2174/1574888x11308010012. View

Borlongan C, Chopp M, Steinberg G, Bliss T, Li Y, Lu M . Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med. 2008; 3(3):249-50. PMC: 7000104. DOI: 10.2217/17460751.3.3.249. View

10.

Wu K, Yu S, Chiang C, Lee Y, Linju Yen B, Hsu C . Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury. Brain Circ. 2018; 4(3):124-127. PMC: 6187942. DOI: 10.4103/bc.bc_16_18. View

11.

Borlongan C, Nguyen H, Lippert T, Russo E, Tuazon J, Xu K . May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells. J Cereb Blood Flow Metab. 2018; 39(2):367-370. PMC: 6365599. DOI: 10.1177/0271678X18811277. View

12.

Nargesi A, Zhu X, Hickson L, Conley S, van Wijnen A, Lerman L . Metabolic Syndrome Modulates Protein Import into the Mitochondria of Porcine Mesenchymal Stem Cells. Stem Cell Rev Rep. 2018; 15(3):427-438. PMC: 6472993. DOI: 10.1007/s12015-018-9855-4. View

13.

Borlongan C, Su T, Wang Y . Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport. 2000; 11(5):923-6. DOI: 10.1097/00001756-200004070-00005. View

14.

Stimpfel M, Jancar N, Virant-Klun I . New Challenge: Mitochondrial Epigenetics?. Stem Cell Rev Rep. 2017; 14(1):13-26. DOI: 10.1007/s12015-017-9771-z. View

15.

Lehmann M, Zappa-Villar M, Garcia M, Mazzolini G, Canatelli-Mallat M, Morel G . Umbilical Cord Cell Therapy Improves Spatial Memory in Aging Rats. Stem Cell Rev Rep. 2019; 15(4):612-617. DOI: 10.1007/s12015-019-09895-2. View

16.

Hu C, Fan L, Cen P, Chen E, Jiang Z, Li L . Energy Metabolism Plays a Critical Role in Stem Cell Maintenance and Differentiation. Int J Mol Sci. 2016; 17(2):253. PMC: 4783982. DOI: 10.3390/ijms17020253. View

17.

Kong C, Subramanian A, Biswas A, Stunkel W, Chong Y, Bongso A . Changes in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton's Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes Mellitus. Stem Cell Rev Rep. 2019; 15(3):415-426. DOI: 10.1007/s12015-019-9872-y. View

18.

Russo E, Lee J, Nguyen H, Corrao S, Anzalone R, La Rocca G . Energy Metabolism Analysis of Three Different Mesenchymal Stem Cell Populations of Umbilical Cord Under Normal and Pathologic Conditions. Stem Cell Rev Rep. 2020; 16(3):585-595. PMC: 7253397. DOI: 10.1007/s12015-020-09967-8. View

19.

Skiles M, Brown K, Tatz W, Swingle K, Brown H . Quantitative analysis of composite umbilical cord tissue health using a standardized explant approach and an assay of metabolic activity. Cytotherapy. 2018; 20(4):564-575. DOI: 10.1016/j.jcyt.2018.01.001. View

20.

Lee J, Tuazon J, Corey S, Bonsack B, Acosta S, Ehrhart J . A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson's Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity. Stem Cell Rev Rep. 2019; 15(5):690-702. PMC: 6731204. DOI: 10.1007/s12015-019-09906-2. View